Thierry Passemar

Title: Thierry Passemar: Innovator in Amino Compound Resolution

Introduction

Thierry Passemar is a notable inventor based in Breuillet, France. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of disorders associated with insulin resistance syndrome. His innovative work has led to the development of a unique process for resolving racemic amino compounds.

Latest Patents

Thierry Passemar holds a patent for a process aimed at resolving aimines that are beneficial for treating insulin resistance syndrome. The patent, titled "Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome," focuses on a method for resolving a racemic amino compound derived from dihydro-1,3,5-triazines. This invention also encompasses the enantiomers of amino derivatives of dihydro-1,3,5-triazines and their application in the preparation of medicaments, particularly for diabetes and malaria. He has 1 patent to his name.

Career Highlights

Throughout his career, Thierry has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Patent GmbH and Poxel S.A.S. His experience in these organizations has allowed him to refine his expertise in drug development and patenting processes.

Collaborations

Thierry has collaborated with esteemed colleagues in his field, including Gérard Moinet and Daniel Cravo. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

In summary, Thierry Passemar is a distinguished inventor whose work in resolving amino compounds has the potential to impact the treatment of significant health issues such as diabetes and malaria. His contributions to medicinal chemistry and collaboration with leading companies highlight his importance in the field.